Zymeworks Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating includes seventeen United Nations SDGs including: 'Gender Equality', 'Climate Action' and 'Partnerships for the Goals'. The webpage of Zymeworks Inc is prepared by All Street Sevva using cutting edge machine learning. Other corporations in the scoring industry group for Zymeworks Inc are shown.
Zymeworks Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.0, social score of 4.8 and governance score of 4.8.
3.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
| 1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | Aclaris Therapeutics Inc | 3.9 | Medium |
| 1089 | Allogene Therapeutics Inc | 3.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Zymeworks Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Zymeworks Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Zymeworks Inc report the average age of the workforce?
Sign up for free to unlockDoes Zymeworks Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Zymeworks Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Zymeworks Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Zymeworks Inc offer flexible work?
Sign up for free to unlockDoes Zymeworks Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Zymeworks Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Zymeworks Inc conduct supply chain audits?
Sign up for free to unlockDoes Zymeworks Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Zymeworks Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Zymeworks Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Zymeworks Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Zymeworks Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Zymeworks Inc disclose water use targets?
Sign up for free to unlockDoes Zymeworks Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Zymeworks Inc have a product recall in the last two years?
Sign up for free to unlockDoes Zymeworks Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Zymeworks Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Zymeworks Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Zymeworks Inc disclose parental leave metrics?
Sign up for free to unlockDoes Zymeworks Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Zymeworks Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Zymeworks Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Zymeworks Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Zymeworks Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Zymeworks Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Zymeworks Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Zymeworks Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Zymeworks Inc disclose its waste policy?
Sign up for free to unlockDoes Zymeworks Inc report according to TCFD requirements?
Sign up for free to unlockDoes Zymeworks Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Zymeworks Inc disclose energy use targets?
Sign up for free to unlockDoes Zymeworks Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Zymeworks Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Zymeworks Inc
These potential risks are based on the size, segment and geographies of the company.
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.